Menu

Blog

Dec 1, 2022

Nanotech strategy shows promise for treating autoimmune disease

Posted by in categories: biotech/medical, chemistry, nanotechnology

Scientists at Scripps Research have reported success in initial tests of a new, nanotech-based strategy against autoimmune diseases.

The scientists, who reported their results in ACS Nano, engineered cell-like “” that target only the driving an autoimmune reaction, leaving the rest of the immune system intact and healthy. The nanoparticles greatly delayed, and in some animals even prevented, in a mouse model of arthritis.

“The potential advantage of this approach is that it would enable safe, long-term treatment for where the immune system attacks its own tissues or organs—using a method that won’t cause broad immune suppression, as current treatments do,” says study senior author James Paulson, Ph.D., Cecil H. and Ida M. Green Chair of Chemistry in the Department of Molecular Medicine at Scripps Research.

Comments are closed.